Cargando…
Backbone and side-chain resonance assignments of the NISTmAb-scFv and antigen-binding study
Monoclonal antibodies (mAbs) therapeutics are the largest and fastest growing class of biologic drugs, amongst which, the vast majority are immunoglobulin G1 (IgG1). Their antigen binding abilities are used for the treatment of immunologic diseases, cancer therapy, reversal of drug effects, and targ...
Autores principales: | Ghasriani, Houman, Ahmadi, Sara, Hodgson, Derek J., Aubin, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510101/ https://www.ncbi.nlm.nih.gov/pubmed/36083574 http://dx.doi.org/10.1007/s12104-022-10109-z |
Ejemplares similares
-
The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability
por: Schiel, John E., et al.
Publicado: (2018) -
Qualification of NISTmAb charge heterogeneity control assays
por: Turner, Abigail, et al.
Publicado: (2018) -
Heterologous recombinant expression of non-originator NISTmAb
por: Kashi, Lila, et al.
Publicado: (2018) -
Development of orthogonal NISTmAb size heterogeneity control methods
por: Turner, Abigail, et al.
Publicado: (2018) -
The NISTmAb Reference Material 8671 lifecycle management and quality plan
por: Schiel, John E., et al.
Publicado: (2018)